Pharmaceutical formula for conditioning respiratory system and preparation process thereof

Abstract

The medicine formula for conditioning the respiratory system is characterized by being prepared from the following raw materials in parts by weight: 8 to 12 parts of radix codonopsis, 13 to 17 parts of rhizoma atractylodis macrocephalae, 8 to 12 parts of poria cocos, 4 to 7 parts of pericarpium citri reticulatae, 8 to 12 parts of rhizoma pinellinae praeparata, 13 to 17 parts of rhizoma polygoni cuspidati, 3 to 7 parts of deer-horn glue, 8 to 12 parts of fructus perillae and 27 to 35 parts of folium artemisiae argyi. The preparation process of the medicine for conditioning the respiratory system is characterized by comprising the following steps: step 1, screening folium artemisiae argyi, and putting the folium artemisiae argyi into a stone groove to be beaten and ground, so that the folium artemisiae argyi is finely crushed into cotton fibers; step 2, sieving the cotton-shaped folium artemisiae argyi obtained in the step 1 to obtain moxa; step 3, screening other medicines, grinding and mixing into medicine powder; step 4, fully mixing the moxa in the step 2 with the medicine powder in the step 3, then rolling the mixture into a cylindrical shape through a plodder, and wrapping and fixing the cylindrical shape with mulberry bark. The device has the advantages that treatment operation is facilitated, and meanwhile the overall treatment effect is improved.

Description

Technical Field

[0001] The present invention relates to the technical field of traditional Chinese medicine, and particularly relates to a drug formula for conditioning the respiratory system and its preparation process. Background Art

[0002] With the development of industrial technology, the waste gas treatment technology of factories has been greatly improved. However, some factories still emit some waste gas, and the operation of vehicles in cities also leads to waste gas emissions. Therefore, the air quality is poor in some indoor environments with poor ventilation conditions, which easily causes employees to suffer from respiratory diseases. In the current existing treatment methods, comprehensive and effective treatment cannot be carried out in the initial stage of the disease. Usually, only effective treatment for a single disease can be carried out. Therefore, the overall treatment effect is poor, and at the same time, the negative effects brought are relatively large, which cannot meet the treatment needs of the actual fast-paced life. Summary of the Invention

[0003] The purpose of the present invention is to provide a drug formula for conditioning the respiratory system and its preparation process, which solves the technical problems of poor treatment effect and inconvenient treatment operation, and realizes the technical effects of improving the treatment effect and facilitating treatment operation.

[0004] In order to achieve the above invention purpose, the technical scheme adopted by the present invention is as follows:

[0005] A drug formula for conditioning the respiratory system, comprising the following raw materials in parts by weight: 8 to 12 parts by weight of Codonopsis pilosula, 13 to 17 parts by weight of Atractylodes macrocephala, 8 to 12 parts by weight of Poria cocos, 4 to 7 parts by weight of Citrus reticulata Blanco, 8 to 12 parts by weight of Pinellia ternata (Thunb.) Breit., 13 to 17 parts by weight of Polygonum cuspidatum Sieb. et Zucc., 3 to 7 parts by weight of Cornu Cervi Colla, 8 to 12 parts by weight of Perilla frutescens (L.) Britt., 27 to 35 parts by weight of Artemisia argyi Levl. et Vant.

[0006] Preferably, it comprises the following raw materials in parts by weight: 9 to 11 parts by weight of Codonopsis pilosula, 14 to 16 parts by weight of Atractylodes macrocephala, 9 to 11 parts by weight of Poria cocos, 5 to 6 parts by weight of Citrus reticulata Blanco, 9 to 11 parts by weight of Pinellia ternata (Thunb.) Breit., 14 to 16 parts by weight of Polygonum cuspidatum Sieb. et Zucc., 4 to 6 parts by weight of Cornu Cervi Colla, 9 to 11 parts by weight of Perilla frutescens (L.) Britt., 29 to 32 parts by weight of Artemisia argyi Levl. et Vant.

[0007] A drug preparation process for conditioning the respiratory system, characterized by comprising the following steps: Step 1: Screen Artemisia argyi Levl. et Vant., and after removing impurities, thick stems and dust, place it in a stone trough for pounding and grinding until it becomes finely divided into cotton-like flocs;

[0008] Step 2: Sieve the cotton-like Artemisia argyi Levl. et Vant. obtained in Step 1 to obtain moxa floss;

[0009] Step 3: Sieve Codonopsis pilosula, Atractylodes macrocephala, Poria cocos, Citrus reticulata Blanco, Pinellia ternata (Thunb.) Breit., Polygonum cuspidatum Sieb. et Zucc., Cornu Cervi Pantotrichum and Perilla frutescens (L.) Britt., and then grind and mix them into a medicinal powder;

[0010] Step 4: Thoroughly mix the moxa wool in Step 2 with the medicinal powder in Step 3, then roll it into a cylindrical shape using a briquetting machine, and wrap and fix it with mulberry bark.

[0011] As an improvement, the time for pounding and grinding in Step 1 is 20 minutes, and the pounding speed is 65 to 70 times per minute. For the sieving process in Step 2, a 150-mesh sieve is required.

[0012] As an improvement, each raw material in Step 3 needs to be washed and dried. After the preparation of the medicinal powder, the overall moisture content should be less than 5%.

[0013] The beneficial effects of the present invention are as follows: By configuring medicinal materials such as Codonopsis pilosula, Atractylodes macrocephala, and Poria cocos and making them into moxa sticks, it can fully treat asthma, allergic cough, and can condition diseases: asthma, allergic cough, tracheitis, bronchitis, chronic obstructive pulmonary disease, pulmonary congestion, cor pulmonale, pulmonary tuberculosis, pulmonary tuberculosis rheumatism, respiratory tract infection, dyspnea, pulmonary infarction, etc. At the same time, it also simplifies the treatment operation steps. Detailed implementation mode

[0014] Now, various exemplary embodiments of the present invention will be described in detail. This detailed description should not be considered as a limitation of the present invention, but should be understood as a more detailed description of certain aspects, characteristics, and implementation schemes of the present invention.

[0015] It should be understood that the terms used in the present invention are only for describing specific embodiments and are not used to limit the present invention. Additionally, for the numerical ranges in the present invention, it should be understood that each intermediate value between the upper and lower limits of the range is also specifically disclosed. Each intermediate value within any stated value or stated range, as well as each smaller range between any other stated value or intermediate value within the stated range, is also included in the present invention. The upper and lower limits of these smaller ranges can be independently included or excluded from the range.

[0016] Unless otherwise specified, all technical and scientific terms used herein have the same meaning as commonly understood by those of ordinary skill in the art to which the present invention pertains. Although the present invention only describes preferred methods and materials, any methods and materials similar or equivalent to those described herein can also be used in the implementation or testing of the present invention. All documents mentioned in this specification are incorporated by reference to disclose and describe the methods and materials related to the documents. In case of conflict with any incorporated document, the content of this specification shall prevail.

[0017] A pharmaceutical formula for regulating the respiratory system, comprising the following raw materials in parts by weight: 8 to 12 parts by weight of Codonopsis pilosula, 13 to 17 parts by weight of Atractylodes macrocephala, 8 to 12 parts by weight of Poria cocos, 4 to 7 parts by weight of Citrus reticulata Blanco, 8 to 12 parts by weight of Pinellia ternata (Thunb.) Breit., 13 to 17 parts by weight of Polygonum cuspidatum Sieb. et Zucc., 3 to 7 parts by weight of Cornu Cervi Colla, 8 to 12 parts by weight of Perilla frutescens (L.) Britt., 27 to 35 parts by weight of Artemisia argyi Levl. et Van.

[0018] When in use, its optimal usage embodiment comprises the following raw materials in parts by weight: 9 to 11 parts by weight of Codonopsis pilosula, 14 to 16 parts by weight of Atractylodes macrocephala, 9 to 11 parts by weight of Poria cocos, 5 to 6 parts by weight of Citrus reticulata Blanco, 9 to 11 parts by weight of Pinellia ternata (Thunb.) Breit., 14 to 16 parts by weight of Polygonum cuspidatum Sieb. et Zucc., 4 to 6 parts by weight of Cornu Cervi Colla, 9 to 11 parts by weight of Perilla frutescens (L.) Britt., 29 to 32 parts by weight of Artemisia argyi Levl. et Van.

[0019] A preparation process of a drug for regulating the respiratory system, characterized by comprising the following steps: Step 1, screen Artemisia argyi Levl. et Van., after removing impurities, thick stems and dust, place it in a stone trough and beat and grind it to make it finely broken into cotton-like; Step 2, sieve the cotton-like Artemisia argyi Levl. et Van. in Step 1 to obtain moxa floss; Step 3, sieve Codonopsis pilosula, Atractylodes macrocephala, Poria cocos, Citrus reticulata Blanco, Pinellia ternata (Thunb.) Breit., Polygonum cuspidatum Sieb. et Zucc., Cornu Cervi Pantotrichum and Perilla frutescens (L.) Britt. and then grind and mix them into a medicinal powder; Step 4, fully mix the moxa floss in Step 2 with the medicinal powder in Step 3, then roll it into a cylindrical shape through a briquetting machine, and use mulberry bark to wrap and fix it. After the wrapping and fixing are completed, it needs to be sealed and stored with plastic wrap or waterproof paper, and the storage temperature needs to be lower than 27 °C.

[0020] The time for beating and grinding in Step 1 is 20 minutes, and the beating speed is 65 to 70 times per minute. The sieving process in Step 2 needs to use a 150-mesh sieve. Each raw material in Step 3 needs to be washed and dried. After the preparation of the medicinal powder, the overall moisture content needs to be less than 5%. When the actual moisture content of the medicinal powder is relatively high, the moisture can be removed by frying, and the frying time does not exceed 10 minutes.

[0021] Usage method of the moxa stick: Select acupoints such as Zhongwan acupoint, Shenque acupoint, Liangmen acupoint, Zusanli acupoint, Weishu acupoint, etc., light the moxa stick, aim it at the acupoints, until it feels warm and comfortable, and stop when the skin turns red. Generally, it is appropriate to moxa each acupoint for 12 - 15 minutes. Alternate before and after once a day, and two weeks is a course of treatment. Observe the curative effect after two courses of treatment.

[0022] The above is only a preferred embodiment of the present invention patent, and it is not intended to limit the present invention patent. Any modifications, equivalent replacements, and improvements made within the spirit and principle of the present invention patent shall be included within the protection scope of the present invention patent.

Claims

1. A pharmaceutical formulation for regulating the respiratory system, characterized in that: The invention comprises the following raw materials in parts by weight: 8 to 12 parts by weight of Codonopsis pilosula, 13 to 17 parts by weight of Atractylodes macrocephala, 8 to 12 parts by weight of Poria cocos, 4 to 7 parts by weight of dried tangerine peel, 8 to 12 parts by weight of Pinellia ternata, 13 to 17 parts by weight of Polygonum cuspidatum, 3 to 7 parts by weight of antler glue, 8 to 12 parts by weight of Perilla seeds and 27 to 35 parts by weight of Artemisia argyi.

2. A pharmaceutical formulation for regulating the respiratory system according to claim 1, characterized in that: The invention comprises the following raw materials in parts by weight: 9 to 11 parts by weight of Codonopsis pilosula, 14 to 16 parts by weight of Atractylodes macrocephala, 9 to 11 parts by weight of Poria cocos, 5 to 6 parts by weight of dried tangerine peel, 9 to 11 parts by weight of Pinellia ternata, 14 to 16 parts by weight of Polygonum cuspidatum, 4 to 6 parts by weight of antler glue, 9 to 11 parts by weight of Perilla seeds and 29 to 32 parts by weight of Artemisia argyi.

3. A process for preparing a drug for regulating the respiratory system according to claim 1, characterized in that: The following steps are involved: Step 1: Screen the mugwort leaves, remove impurities, thick stems and dust, and then beat and grind them in a stone trough to make them into cotton-like pieces; Step 2, sieving the cotton-like wormwood leaves in step 1 to obtain wormwood fluff; Step 3, sieving and grinding the codonopsis pilosula, atractylodes macrocephala, tuckahoe, tangerine peel, pinellia tuber, polygonum cuspidatum, antler velvet and perilla seed into powder; Step 4: Fully mix the moxa in step 2 and the medicinal powder in step 3, then roll them into a cylindrical shape using a plodder, and wrap and fix them with mulberry bark.

4. The preparation process of a drug for regulating the respiratory system according to claim 3, characterized in that: The pounding and grinding time in step 1 is 20 minutes, the pounding speed is 65 to 70 times per minute, and the screening process in step 2 requires the use of a 150-mesh screen.

5. The preparation process of a drug for regulating the respiratory system according to claim 1, characterized in that: In step 3, each raw material needs to be washed and dried, and after the preparation of the medicine powder is completed, the overall moisture content must be less than 5%.